← Research library

Neuroepigenetic Mechanisms of Action of Ultrashort Peptides in Alzheimer’s Disease

Review of earlier studies · 2022

What was studied
Review of earlier research
Main finding
Develops hypotheses connecting short peptides with gene regulation and neurodegenerative processes. Hypotheses are retained as mechanistic proposals, not clinical conclusions.

Study data at a glance

Participants or experimental model
Review of earlier research
Reported results
Develops hypotheses connecting short peptides with gene regulation and neurodegenerative processes. Hypotheses are retained as mechanistic proposals, not clinical conclusions.
Study limitations and source details

Study limitations

  • Source-linked does not mean a completed risk-of-bias review.
  • A review is not an independent clinical replication; proposed mechanisms do not establish efficacy or safety.

Source details

Source scope and bibliographic record checked; see the original experiments for methods and results.

Sources checked

Citation

ReviewFull text available

Author list available on linked original paper. Neuroepigenetic Mechanisms of Action of Ultrashort Peptides in Alzheimer’s Disease International Journal of Molecular Sciences 23(8):4259

Study source ↗ · DOI 10.3390/ijms23084259 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards